4JQI image
Entry Detail
PDB ID:
4JQI
Title:
Structure of active beta-arrestin1 bound to a G protein-coupled receptor phosphopeptide
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2013-03-20
Release Date:
2013-04-17
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
I 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Beta-arrestin-1
Chain IDs:A
Chain Length:401
Number of Molecules:1
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Description:Fab30 heavy chain
Chain IDs:B (auth: H)
Chain Length:237
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Fab30 light chain
Chain IDs:C (auth: L)
Chain Length:215
Number of Molecules:1
Biological Source:Mus musculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP D SER PHOSPHOSERINE
TPO D THR PHOSPHOTHREONINE
Primary Citation
Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide.
Nature 497 137 141 (2013)
PMID: 23604254 DOI: 10.1038/nature12120

Abstact

The functions of G-protein-coupled receptors (GPCRs) are primarily mediated and modulated by three families of proteins: the heterotrimeric G proteins, the G-protein-coupled receptor kinases (GRKs) and the arrestins. G proteins mediate activation of second-messenger-generating enzymes and other effectors, GRKs phosphorylate activated receptors, and arrestins subsequently bind phosphorylated receptors and cause receptor desensitization. Arrestins activated by interaction with phosphorylated receptors can also mediate G-protein-independent signalling by serving as adaptors to link receptors to numerous signalling pathways. Despite their central role in regulation and signalling of GPCRs, a structural understanding of β-arrestin activation and interaction with GPCRs is still lacking. Here we report the crystal structure of β-arrestin-1 (also called arrestin-2) in complex with a fully phosphorylated 29-amino-acid carboxy-terminal peptide derived from the human V2 vasopressin receptor (V2Rpp). This peptide has previously been shown to functionally and conformationally activate β-arrestin-1 (ref. 5). To capture this active conformation, we used a conformationally selective synthetic antibody fragment (Fab30) that recognizes the phosphopeptide-activated state of β-arrestin-1. The structure of the β-arrestin-1-V2Rpp-Fab30 complex shows marked conformational differences in β-arrestin-1 compared to its inactive conformation. These include rotation of the amino- and carboxy-terminal domains relative to each other, and a major reorientation of the 'lariat loop' implicated in maintaining the inactive state of β-arrestin-1. These results reveal, at high resolution, a receptor-interacting interface on β-arrestin, and they indicate a potentially general molecular mechanism for activation of these multifunctional signalling and regulatory proteins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures